Ramin Massoumi

Ramin Massoumi


Personal profile


Molecular targeted therapy by using a drug that reduces the growth and spread of cancer cells via inhibition of a specific protein is a foundation stone of precision medicine and treatment. The main objective of our research is to identify lead molecules that selectively inhibit proliferation and metastasis of cancer cells originating from colon, prostate, breast, and skin. These tumors are the four top cancer diseases in Sweden and worldwide with highest prevalence. Therefore, there is an urgent need for development of novel drugs that can cure or prolong the survival of these patients. At the initial step and as a proof of concept, we are focusing on metastatic melanoma as a model system. Furthermore, the therapeutic market of melanoma has significant unmet needs in terms of safety of drug treatment and efficacy profiles. Our research activates aim at multi-parameter lead optimization, preclinical and clinical verification to generate a safe and efficacious drug. We hope to achieve positive response of targeted therapy in clinical trials and as a new innovative strategy for cancer patients.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

UKÄ subject classification

  • Cancer and Oncology

Free keywords

  • Small molecules
  • Animal Models


Dive into the research topics where Ramin Massoumi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or